Homocysteine as a neurotoxin in chronic alcoholism - PubMed (original) (raw)
Review
Homocysteine as a neurotoxin in chronic alcoholism
Stefan Bleich et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 May.
Abstract
There is evidence from in vitro and in vivo studies that homocysteine induces neuronal damage and cell loss by both excitotoxicity and different apoptotic processes. Clinical evidence suggest a strong relationship between higher plasma homocysteine levels and brain atrophy in healthy elderly subjects as well as in elderly at risk of and with Alzheimer's disease. Chronic alcoholism leads to elevated plasma homocysteine levels, as shown by clinical investigations and animal experiments. In addition, an association between brain atrophy and increased levels of homocysteine in chronic alcoholism was shown. This may have important implications for the pathogenesis of alcoholism-associated brain atrophy. Furthermore, taking into account that high plasma homocysteine levels are helpful in the prediction of alcohol withdrawal seizures, early anticonvulsive therapy could prevent this severe complication. Homocysteine plays a role in a shared biochemical cascade involving overstimulation of N-methyl-D-aspartate (NMDA) receptors, oxidative stress, activation of caspases, DNA damage, endoplasmic reticulum and mitochondrial dysfunction. These mechanisms are believed to be important in the pathogenesis of both excitotoxicity and apoptotic neurotoxicity. Prospective intervention studies may show whether the incidence of complications of alcohol withdrawal or alcoholism-associated disorders can be reduced by therapeutic measures with early lowering of elevated homocysteine levels (e.g. folate administration). The most important pathophysiological and pathobiochemical features of glutamatergic neurotransmission and of ethanol-induced hyperhomocysteinaemia are reviewed in relation to their excitotoxic and apoptotic potential.
Similar articles
- [Excitatory neurotransmission in alcoholism].
Bleich S, Sperling W, Wiltfang J, Maler JM, Kornhuber J. Bleich S, et al. Fortschr Neurol Psychiatr. 2003 Jul;71 Suppl 1:S36-44. doi: 10.1055/s-2003-40504. Fortschr Neurol Psychiatr. 2003. PMID: 12947542 Review. German. - Homocysteine and brain atrophy.
Sachdev PS. Sachdev PS. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Sep;29(7):1152-61. doi: 10.1016/j.pnpbp.2005.06.026. Prog Neuropsychopharmacol Biol Psychiatry. 2005. PMID: 16102882 Review. - Homocysteine, alcoholism and its molecular networks.
Bleich S, Hillemacher T. Bleich S, et al. Pharmacopsychiatry. 2009 May;42 Suppl 1:S102-9. doi: 10.1055/s-0029-1214396. Epub 2009 May 11. Pharmacopsychiatry. 2009. PMID: 19434547 Review. - [Folate against hyperhomocysteinemia. A new approach for the prevention and therapy of alcoholism-associated disorders?].
Bleich S, Löffelholz K, Kornhuber J. Bleich S, et al. Nervenarzt. 2004 May;75(5):425-30. doi: 10.1007/s00115-003-1606-2. Nervenarzt. 2004. PMID: 15252882 Review. German. - Alcoholism-associated hyperhomocysteinemia and previous withdrawal seizures.
Bayerlein K, Hillemacher T, Reulbach U, Mugele B, Sperling W, Kornhuber J, Bleich S. Bayerlein K, et al. Biol Psychiatry. 2005 Jun 15;57(12):1590-3. doi: 10.1016/j.biopsych.2005.01.046. Biol Psychiatry. 2005. PMID: 15953497
Cited by
- Homocysteine, Alcoholism, and Its Potential Epigenetic Mechanism.
Kamat PK, Mallonee CJ, George AK, Tyagi SC, Tyagi N. Kamat PK, et al. Alcohol Clin Exp Res. 2016 Dec;40(12):2474-2481. doi: 10.1111/acer.13234. Epub 2016 Nov 2. Alcohol Clin Exp Res. 2016. PMID: 27805256 Free PMC article. Review. - Biological markers to predict previous alcohol withdrawal seizures: a risk assessment.
Hillemacher T, Frieling H, Bayerlein K, Wilhelm J, Kornhuber J, Bleich S. Hillemacher T, et al. J Neural Transm (Vienna). 2007 Feb;114(2):151-4. doi: 10.1007/s00702-006-0541-3. Epub 2006 Aug 10. J Neural Transm (Vienna). 2007. PMID: 16897604 - Chronic alcohol consumption and its effect on nodes of frontocerebellar and limbic circuitry: comparison of effects in France and the United States.
Le Berre AP, Pitel AL, Chanraud S, Beaunieux H, Eustache F, Martinot JL, Reynaud M, Martelli C, Rohlfing T, Sullivan EV, Pfefferbaum A. Le Berre AP, et al. Hum Brain Mapp. 2014 Sep;35(9):4635-53. doi: 10.1002/hbm.22500. Epub 2014 Mar 17. Hum Brain Mapp. 2014. PMID: 24639416 Free PMC article. - Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in rats.
Alirezaei M. Alirezaei M. Iran J Basic Med Sci. 2015 Oct;18(10):950-7. Iran J Basic Med Sci. 2015. PMID: 26730328 Free PMC article. - Overview: how is alcohol metabolized by the body?
Zakhari S. Zakhari S. Alcohol Res Health. 2006;29(4):245-54. Alcohol Res Health. 2006. PMID: 17718403 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical